An implantable loop recorder (ILR) has been available for several years. The Reveal ILR (Medtronic, Minneapolis, MN) is a 6.1 × 1.9 × 0.8 cm device with two bipolar electrodes on its shell.

A smart algorithm is a key element of an innovative closed loop insulin pump system which aims to mimic the function of a healthy pancreas. Paid and presented by Medtronic. Over 42 million people ...

For instance, in 2016, Medtronic created the first hybrid closed-loop insulin delivery system; in 2017, it made the world's smallest spinal cord stimulator implant. Is Medtronic the Largest ...

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the ...

Principle physician education specialist Jakub David and principle mapping specialist Tim Sorrell Jr. perform a training exercise with the Affera Mapping and Ablation System with Sphere-9 Catheter ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) healthcare behemoth. Medtronic has increased its dividend for 47 ...

Shares of Medtronic PLC climbed toward a three-month high in early Tuesday trading, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top five robotic surgeons in the U.S. James Porter serves as medical ...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...